info@marketresearchfuture.com   ๐Ÿ“ž  +1 (855) 661-4441(US)   ๐Ÿ“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersโ€™ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Unnatural Amino Acids Market Research Report Information By Type (D-Amino Acids & Derivatives, DL-Amino Acids & Derivatives, B-Amino Acids & Derivatives, Cyclic Amino Acids & Derivatives, L-Amino Acid Derivatives, Gamma-Amino Butyric Acid {GABA}, Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB), Synthetic-Amino Acids, Others), By Application (Liver Diseases, Cancer, Inflammatory Disease, Genetic Diseases), By End-User (Pharmaceutical & Biotechnological, Companies, Research Laboratories) And By Region (North America, Europe, Asia-Pacific, And Re


ID: MRFR/Pharma/3479-CR | 216 Pages | Author: Rahul Gotadki| July 2020

Market Segmentation


Unnatural Amino Acids Type Outlook (USD Billion, 2018-2032)




  • D-Amino Acids & Derivatives




  • DL-Amino Acids & Derivatives




  • B-Amino Acids & Derivatives




  • Cyclic Amino Acids & Derivatives




  • Gamma-Amino Butyric Acid {GABA}




  • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




  • L-Amino Acid Derivatives




  • Synthetic-Amino Acids




  • Others




Unnatural Amino Acids Application Outlook (USD Billion, 2018-2032)




  • Liver Diseases




  • Cancer




  • Inflammatory Disease




  • Genetic Diseases




Unnatural Amino Acids End-User Outlook (USD Billion, 2018-2032)




  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories




Unnatural Amino Acids Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America Unnatural Amino Acids by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • North America Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases










  • North America Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories







    • US Outlook (USD Billion, 2018-2032)




    • US Unnatural Amino Acids by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • US Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • US Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories







    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA Cyber Insurance by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • CANADA Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • CANADA Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories






  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Cyber Insurance by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • Europe Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases










  • Europe Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Liver Diseases




  • Research Laboratories







    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Cyber Insurance by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • Germany Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • Germany Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories







    • France Outlook (USD Billion, 2018-2032)




    • France Cyber Insurance by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • France Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • France Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories







    • UK Outlook (USD Billion, 2018-2032)




    • UK Cyber Insurance by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • UK Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • UK Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories







    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY Cyber Insurance by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • ITALY Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • ITALY Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories







    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain Unnatural Amino Acids by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • Spain Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • Spain Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories






  • Rest Of Europe Outlook (USD Billion, 2018-2032)







    • Rest Of Europe Unnatural Amino Acids by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • REST OF EUROPE Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • REST OF EUROPE Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories






  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Cyber Insurance by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • Asia-Pacific Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases










  • Asia-Pacific Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Liver Diseases




  • Research Laboratories







    • China Outlook (USD Billion, 2018-2032)




    • China Cyber Insurance by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • China Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • China Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories







    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Cyber Insurance by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • Japan Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • Japan Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories







    • India Outlook (USD Billion, 2018-2032)




    • India Unnatural Amino Acids by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • India Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • India Cyber Insurance by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories







    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Cyber Insurance by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • Australia Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • Australia Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories






  • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)







    • Rest of Asia-Pacific Cyber Insurance by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • Rest of Asia-Pacific Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • Rest of Asia-Pacific Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories






  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Unnatural Amino Acids by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • Rest of the World Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases










  • Rest of the World Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories







    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Unnatural Amino Acids by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • Middle East Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • Middle East Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Liver Diseases




  • Research Laboratories







    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Cyber Insurance by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • Africa Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • Africa Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories







    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Cyber Insurance by Type




      • D-Amino Acids & Derivatives




      • DL-Amino Acids & Derivatives




      • B-Amino Acids & Derivatives




      • Cyclic Amino Acids & Derivatives




      • Gamma-Amino Butyric Acid {GABA}




      • Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)




      • L-Amino Acid Derivatives




      • Synthetic-Amino Acids




      • Others






    • Latin America Unnatural Amino Acids by Application




      • Liver Diseases




      • Cancer




      • Inflammatory Disease




      • Genetic Diseases









  • Latin Unnatural Amino Acids by End-User






  • Pharmaceutical & Biotechnological




  • Companies




  • Research Laboratories



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION 18

2.2 SCOPE OF THE STUDY 18

2.3 RESEARCH OBJECTIVE 18

2.4 MARKET STRUCTURE 18

2.5 ASSUMPTIONS & LIMITATIONS 19

3 RESEARCH METHODOLOGY

3.1 DATA MINING 20

3.2 SECONDARY RESEARCH 21

3.3 PRIMARY RESEARCH 22

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 23

3.5 FORECASTING TECHNIQUES 23

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 24

3.6.1 BOTTOM-UP APPROACH 25

3.6.2 TOP-DOWN APPROACH 26

3.7 DATA TRIANGULATION 26

3.8 VALIDATION 27

4 MARKET DYNAMICS

4.1 OVERVIEW 28

4.2 DRIVERS 29

4.2.1 RISING APPLICATIONS OF UNNATURAL AMINO ACIDS IN PHARMACEUTICALS 29

4.2.2 INCREASING CHRONIC DISORDERS 29

4.2.3 RISING PHARMACEUTICAL INDUSTRY 29

4.3 RESTRAINTS 30

4.3.1 STRINGENT GOVERNMENT REGULATIONS 30

4.3.2 IMPACT OF COVID-19 30

4.4 CHALLENGES 31

4.4.1 LACK OF RESEARCH AND DEVELOPMENT IN UNDERDEVELOPED REGIONS 31

5 MARKET FACTOR ANALYSIS

5.1 PORTERโ€™S FIVE FORCES MODEL 32

5.1.1 THREAT OF NEW ENTRANTS 33

5.1.2 BARGAINING POWER OF SUPPLIERS 33

5.1.3 THREAT OF SUBSTITUTES 33

5.1.4 BARGAINING POWER OF BUYERS 33

5.1.5 INTENSITY OF RIVALRY 33

5.2 VALUE CHAIN ANALYSIS 34

5.2.1 R&D AND DESIGNING 35

5.2.2 MANUFACTURING 35

5.2.3 DISTRIBUTION 35

5.2.4 MARKETING & SALES 35

5.2.5 POST-SALES MONITORING 35

6 GLOBAL UNNATURAL AMINO ACIDS MARKET, BY TYPE

6.1 OVERVIEW 36

6.2 D-AMINO ACIDS & DERIVATIVES 38

6.3 DL-AMINO ACIDS & DERIVATIVES 40

6.4 ฮ’-AMINO ACIDS & DERIVATIVES 41

6.5 CYCLIC AMINO ACIDS & DERIVATIVES 42

6.6 L-AMINO ACID DERIVATIVES 43

6.7 GAMMA-AMINO BUTYRIC ACID (GABA) 44

6.8 GAMMA-AMINO-BETA-HYDROXYBUTYRIC ACID (GABOB) 44

6.9 SYNTHETIC-AMINO ACIDS 45

7 GLOBAL UNNATURAL AMINO ACIDS MARKET, BY APPLICATION

7.1 OVERVIEW 46

7.2 LIVER DISEASES 48

7.3 CANCER 48

7.4 INFLAMMATORY DISEASE 49

7.5 GENETIC DISEASES 49

8 GLOBAL UNNATURAL AMINO ACIDS MARKET, BY END USER

8.1 OVERVIEW 50

8.2 PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES 52

8.3 RESEARCH LABORATORIES 52

8.4 ACADEMIC INSTITUTES 53

9 GLOBAL UNNATURAL AMINO ACIDS MARKET, BY REGION

9.1 OVERVIEW 54

9.2 AMERICAS 56

9.2.1 NORTH AMERICA 62

9.2.1.1 US 68

9.2.1.2 CANADA 73

9.2.2 LATIN AMERICA 78

9.3 EUROPE 83

9.3.1 WESTERN EUROPE 89

9.3.1.1 GERMANY 95

9.3.1.2 FRANCE 100

9.3.1.3 UK 105

9.3.1.4 ITALY 110

9.3.1.5 SPAIN 115

9.3.1.6 REST OF WESTERN EUROPE 120

9.3.2 EASTERN EUROPE 125

9.4 ASIA-PACIFIC 130

9.4.1 INDIA 136

9.4.2 CHINA 141

9.4.3 JAPAN 146

9.4.4 AUSTRALIA 151

9.4.5 SOUTH KOREA 156

9.4.6 REST OF ASIA-PACIFIC 161

9.5 MIDDLE EAST & AFRICA 166

9.5.1 MIDDLE EAST 172

9.5.2 AFRICA 177

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW 182

10.2 MAJOR PLAYERS IN THE GLOBAL UNNATURAL AMINO ACIDS MARKET 182

10.3 COMPETITIVE BENCHMARKING 183

10.4 COMPETITOR DASHBOARD 184

10.5 MAJOR GROWTH STRATEGIES IN THE GLOBAL UNNATURAL AMINO ACIDS MARKET 184

10.6 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL UNNATURAL AMINO ACIDS MARKET 185

10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 185

10.7.1 ACQUISITIONS 185

10.7.2 EXPANSIONS 185

10.7.3 AGREEMENTS 186

11 COMPANY PROFILES

11.1 MERCK KGAA 187

11.1.1 COMPANY OVERVIEW 187

11.1.2 FINANCIAL OVERVIEW 188

11.1.3 PRODUCTS/SERVICES OFFERED 188

11.1.4 KEY DEVELOPMENTS 189

11.1.5 SWOT ANALYSIS 190

11.1.6 KEY STRATEGIES 190

11.2 AJINOMOTO CO., INC. 191

11.2.1 COMPANY OVERVIEW 191

11.2.2 FINANCIAL OVERVIEW 191

11.2.3 PRODUCTS/SERVICES OFFERED 192

11.2.4 KEY DEVELOPMENTS 192

11.2.5 SWOT ANALYSIS 193

11.2.6 KEY STRATEGIES 193

11.3 BASF SE 194

11.3.1 COMPANY OVERVIEW 194

11.3.2 FINANCIAL OVERVIEW 194

11.3.3 PRODUCTS/SERVICES OFFERED 195

11.3.4 KEY DEVELOPMENTS 195

11.3.5 SWOT ANALYSIS 195

11.3.6 KEY STRATEGIES 196

11.4 ENZO LIFE SCIENCES, INC. 197

11.4.1 COMPANY OVERVIEW 197

11.4.2 FINANCIAL OVERVIEW 197

11.4.3 PRODUCTS/SERVICES OFFERED 198

11.4.4 KEY DEVELOPMENTS 198

11.4.5 SWOT ANALYSIS 198

11.4.6 KEY STRATEGIES 199

11.5 AMINOLOGICS CO., LTD 200

11.5.1 COMPANY OVERVIEW 200

11.5.2 FINANCIAL OVERVIEW 200

11.5.3 PRODUCTS/SERVICES OFFERED 200

11.5.4 KEY DEVELOPMENTS 200

11.5.5 SWOT ANALYSIS 201

11.5.6 KEY STRATEGIES 201

11.6 ANASPEC, INC. 202

11.6.1 COMPANY OVERVIEW 202

11.6.2 FINANCIAL OVERVIEW 202

11.6.3 PRODUCTS/SERVICES OFFERED 203

11.6.4 KEY DEVELOPMENTS 203

11.6.5 SWOT ANALYSIS 204

11.6.6 KEY STRATEGIES 204

11.7 HANHONG SCIENTIFIC 205

11.7.1 COMPANY OVERVIEWS 205

11.7.2 FINANCIAL OVERVIEW 205

11.7.3 PRODUCTS/SERVICES OFFERED 205

11.7.4 KEY DEVELOPMENTS 205

11.7.5 SWOT ANALYSIS 206

11.7.6 KEY STRATEGIES 206

11.8 BIO-TECHNE CORPORATION 207

11.8.1 COMPANY OVERVIEW 207

11.8.2 FINANCIAL OVERVIEW 208

11.8.3 PRODUCTS/SERVICES OFFERED 209

11.8.4 KEY DEVELOPMENTS 209

11.8.5 SWOT ANALYSIS 209

11.8.6 KEY STRATEGIES 210

11.9 TOKYO CHEMICAL INDUSTRY CO., LTD 211

11.9.1 COMPANY OVERVIEW 211

11.9.2 FINANCIAL OVERVIEW 211

11.9.3 PRODUCTS/SERVICES OFFERED 211

11.9.4 KEY DEVELOPMENTS 212

11.9.5 SWOT ANALYSIS 212

11.9.6 KEY STRATEGIES 213

11.10 YONEYAMA YAKUHIN KOGYO CO., LTD 214

11.10.1 COMPANY OVERVIEW 214

11.10.2 FINANCIAL OVERVIEW 214

11.10.3 PRODUCTS/SERVICES OFFERED 214

11.10.4 KEY DEVELOPMENTS 214

11.10.5 SWOT ANALYSIS 215

11.10.6 KEY STRATEGIES 215

12 APPENDIX

12.1 REFERENCES 216

12.2 RELATED REPORTS 216

13 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 19

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 22

TABLE 3 GLOBAL UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 38

TABLE 4 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY REGION, 2023โ€“2030 (USD MILLION) 38

TABLE 5 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 39

TABLE 6 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY REGION, 2023โ€“2030 (USD MILLION) 40

TABLE 7 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 40

TABLE 8 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY REGION, 2023โ€“2030 (USD MILLION) 41

TABLE 9 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 41

TABLE 10 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY REGION, 2023โ€“2030 (USD MILLION) 42

TABLE 11 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 42

TABLE 12 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY REGION, 2023โ€“2030 (USD MILLION) 43

TABLE 13 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 43

TABLE 14 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR GAMMA-AMINO BUTYRIC ACID (GABA), BY REGION, 2023โ€“2030

(USD MILLION) 44

TABLE 15 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR GAMMA-AMINO-BETA-HYDROXYBUTYRIC ACID (GABOB), BY REGION, 2023โ€“2030 (USD MILLION) 44

TABLE 16 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR SYNTHETIC AMINO ACIDS & DERIVATIVES, BY REGION, 2023โ€“2030 (USD MILLION) 45

TABLE 17 GLOBAL UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 47

TABLE 18 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR LIVER DISEASES, BY REGION, 2023โ€“2030 (USD MILLION) 48

TABLE 19 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR CANCER, BY REGION, 2023โ€“2030 (USD MILLION) 48

TABLE 20 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR INFLAMMATORY DISEASES, BY REGION, 2023โ€“2030 (USD MILLION) 49

TABLE 21 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR GENETIC DISEASES, BY REGION, 2023โ€“2030 (USD MILLION) 49

TABLE 22 GLOBAL UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 51

TABLE 23 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES, BY REGION, 2023โ€“2030 (USD MILLION) 52

TABLE 24 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR RESEARCH LABORATORIES, BY REGION, 2023โ€“2030 (USD MILLION) 52

TABLE 25 GLOBAL UNNATURAL AMINO ACIDS MARKET, FOR ACADEMIC INSTITUTES, BY REGION, 2023โ€“2030 (USD MILLION) 53

TABLE 26 GLOBAL UNNATURAL AMINO ACIDS MARKET, BY REGION, 2023โ€“2030 (USD MILLION) 55

TABLE 27 AMERICAS: UNNATURAL AMINO ACIDS MARKET, BY REGION, 2023โ€“2030 (USD MILLION) 56

TABLE 28 AMERICAS: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 57

TABLE 29 AMERICAS: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 58

TABLE 30 AMERICAS: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 59

TABLE 31 AMERICAS: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 59

TABLE 32 AMERICAS: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 60

TABLE 33 AMERICAS: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 60

TABLE 34 AMERICAS: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 61

TABLE 35 AMERICAS: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 61

TABLE 36 NORTH AMERICA: UNNATURAL AMINO ACIDS MARKET, BY COUNTRY, 2023โ€“2030 (USD MILLION) 62

TABLE 37 NORTH AMERICA: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 63

TABLE 38 NORTH AMERICA: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 64

TABLE 39 NORTH AMERICA: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 65

TABLE 40 NORTH AMERICA: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 65

TABLE 41 NORTH AMERICA: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 66

TABLE 42 NORTH AMERICA: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 66

TABLE 43 NORTH AMERICA: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 67

TABLE 44 NORTH AMERICA: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 67

TABLE 45 US: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 68

TABLE 46 US: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 69

TABLE 47 US: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 70

TABLE 48 US: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 70

TABLE 49 US: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 71

TABLE 50 US: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 71

TABLE 51 US: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 72

TABLE 52 US: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 72

TABLE 53 CANADA: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 73

TABLE 54 CANADA: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 74

TABLE 55 CANADA: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 75

TABLE 56 CANADA: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 75

TABLE 57 CANADA: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 76

TABLE 58 CANADA: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 76

TABLE 59 CANADA: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 77

TABLE 60 CANADA: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 77

TABLE 61 LATIN AMERICA: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 78

TABLE 62 LATIN AMERICA: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 79

TABLE 63 LATIN AMERICA: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 80

TABLE 64 LATIN AMERICA: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 80

TABLE 65 LATIN AMERICA: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 81

TABLE 66 LATIN AMERICA: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 81

TABLE 67 LATIN AMERICA: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 82

TABLE 68 LATIN AMERICA: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 82

TABLE 69 EUROPE: UNNATURAL AMINO ACIDS MARKET, BY REGION, 2023โ€“2030 (USD MILLION) 83

TABLE 70 EUROPE: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 84

TABLE 71 EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 85

TABLE 72 EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 86

TABLE 73 EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 86

TABLE 74 EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 87

TABLE 75 EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 87

TABLE 76 EUROPE: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 88

TABLE 77 EUROPE: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 88

TABLE 78 WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, BY COUNTRY, 2023โ€“2030 (USD MILLION) 89

TABLE 79 WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 90

TABLE 80 WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 91

TABLE 81 WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 92

TABLE 82 WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 92

TABLE 83 WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 93

TABLE 84 WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 93

TABLE 85 WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 94

TABLE 86 WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 94

TABLE 87 GERMANY: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 95

TABLE 88 GERMANY: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 96

TABLE 89 GERMANY: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 97

TABLE 90 GERMANY: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 97

TABLE 91 GERMANY: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 98

TABLE 92 GERMANY: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 98

TABLE 93 GERMANY: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 99

TABLE 94 GERMANY: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 99

TABLE 95 FRANCE: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 100

TABLE 96 FRANCE: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 101

TABLE 97 FRANCE: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 102

TABLE 98 FRANCE: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 102

TABLE 99 FRANCE: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 103

TABLE 100 FRANCE: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 103

TABLE 101 FRANCE: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 104

TABLE 102 FRANCE: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 104

TABLE 103 UK: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 105

TABLE 104 UK: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 106

TABLE 105 UK: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 107

TABLE 106 UK: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 107

TABLE 107 UK: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 108

TABLE 108 UK: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 108

TABLE 109 UK: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 109

TABLE 110 UK: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 109

TABLE 111 ITALY: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 110

TABLE 112 ITALY: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 111

TABLE 113 ITALY: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 112

TABLE 114 ITALY: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 112

TABLE 115 ITALY: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 113

TABLE 116 ITALY: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 113

TABLE 117 ITALY: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 114

TABLE 118 ITALY: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 114

TABLE 119 SPAIN: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 115

TABLE 120 SPAIN: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 116

TABLE 121 SPAIN: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 117

TABLE 122 SPAIN: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 117

TABLE 123 SPAIN: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 118

TABLE 124 SPAIN: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 118

TABLE 125 SPAIN: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 119

TABLE 126 SPAIN: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 119

TABLE 127 REST OF WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 120

TABLE 128 REST OF WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 121

TABLE 129 REST OF WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 122

TABLE 130 REST OF WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 122

TABLE 131 REST OF WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 123

TABLE 132 REST OF WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 123

TABLE 133 REST OF WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 124

TABLE 134 REST OF WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 124

TABLE 135 EASTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 125

TABLE 136 EASTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 126

TABLE 137 EASTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 127

TABLE 138 EASTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 127

TABLE 139 EASTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 128

TABLE 140 EASTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 128

TABLE 141 EASTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 129

TABLE 142 EASTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 129

TABLE 143 ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, BY COUNTRY, 2023โ€“2030 (USD MILLION) 130

TABLE 144 ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 131

TABLE 145 ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 132

TABLE 146 ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 133

TABLE 147 ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 133

TABLE 148 ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 134

TABLE 149 ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 134

TABLE 150 ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 135

TABLE 151 ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 135

TABLE 152 INDIA: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 136

TABLE 153 INDIA: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 137

TABLE 154 INDIA: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 138

TABLE 155 INDIA: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 138

TABLE 156 INDIA: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 139

TABLE 157 INDIA: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 139

TABLE 158 INDIA: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 140

TABLE 159 INDIA: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 140

TABLE 160 CHINA: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 141

TABLE 161 CHINA: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 142

TABLE 162 CHINA: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 143

TABLE 163 CHINA: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 143

TABLE 164 CHINA: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 144

TABLE 165 CHINA: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 144

TABLE 166 CHINA: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 145

TABLE 167 CHINA: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 145

TABLE 168 JAPAN: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 146

TABLE 169 JAPAN: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 147

TABLE 170 JAPAN: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 148

TABLE 171 JAPAN: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 148

TABLE 172 JAPAN: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 149

TABLE 173 JAPAN: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 149

TABLE 174 JAPAN: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 150

TABLE 175 JAPAN: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 150

TABLE 176 AUSTRALIA: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 151

TABLE 177 AUSTRALIA: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 152

TABLE 178 AUSTRALIA: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 153

TABLE 179 AUSTRALIA: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 153

TABLE 180 AUSTRALIA: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 154

TABLE 181 AUSTRALIA: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 154

TABLE 182 AUSTRALIA: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 155

TABLE 183 AUSTRALIA: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 155

TABLE 184 SOUTH KOREA: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 156

TABLE 185 SOUTH KOREA: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 157

TABLE 186 SOUTH KOREA: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 158

TABLE 187 SOUTH KOREA: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 158

TABLE 188 SOUTH KOREA: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 159

TABLE 189 SOUTH KOREA: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 159

TABLE 190 SOUTH KOREA: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 160

TABLE 191 SOUTH KOREA: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 160

TABLE 192 REST OF ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 161

TABLE 193 REST OF ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 162

TABLE 194 REST OF ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 163

TABLE 195 REST OF ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 163

TABLE 196 REST OF ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 164

TABLE 197 REST OF ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 164

TABLE 198 REST OF ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 165

TABLE 199 REST OF ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 165

TABLE 200 MIDDLE EAST & AFRICA: UNNATURAL AMINO ACIDS MARKET, BY REGION, 2023โ€“2030 (USD MILLION) 166

TABLE 201 MIDDLE EAST & AFRICA: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 167

TABLE 202 MIDDLE EAST & AFRICA: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 168

TABLE 203 MIDDLE EAST & AFRICA: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 169

TABLE 204 MIDDLE EAST & AFRICA: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 169

TABLE 205 MIDDLE EAST & AFRICA: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 170

TABLE 206 MIDDLE EAST & AFRICA: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 170

TABLE 207 MIDDLE EAST & AFRICA: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 171

TABLE 208 MIDDLE EAST & AFRICA: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 171

TABLE 209 MIDDLE EAST: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 172

TABLE 210 MIDDLE EAST: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 173

TABLE 211 MIDDLE EAST: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 174

TABLE 212 MIDDLE EAST: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 174

TABLE 213 MIDDLE EAST: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030

(USD MILLION) 175

TABLE 214 MIDDLE EAST: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 175

TABLE 215 MIDDLE EAST: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 176

TABLE 216 MIDDLE EAST: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 176

TABLE 217 AFRICA: UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023โ€“2030 (USD MILLION) 177

TABLE 218 AFRICA: UNNATURAL AMINO ACIDS MARKET, FOR D-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 178

TABLE 219 AFRICA: UNNATURAL AMINO ACIDS MARKET, FOR DL-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 179

TABLE 220 AFRICA: UNNATURAL AMINO ACIDS MARKET, FOR B-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 179

TABLE 221 AFRICA: UNNATURAL AMINO ACIDS MARKET, FOR CYCLIC AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 180

TABLE 222 AFRICA: UNNATURAL AMINO ACIDS MARKET, FOR L-AMINO ACIDS & DERIVATIVES, BY TYPE, 2023โ€“2030 (USD MILLION) 180

TABLE 223 AFRICA: UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023โ€“2030 (USD MILLION) 181

TABLE 224 AFRICA: UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023โ€“2030 (USD MILLION) 181

TABLE 225 MAJOR PLAYERS IN THE GLOBAL UNNATURAL AMINO ACIDS MARKET 182

TABLE 226 COMPETITOR DASHBOARD: GLOBAL UNNATURAL AMINO ACIDS MARKET 184

TABLE 227 THE MOST ACTIVE PLAYER IN THE GLOBAL UNNATURAL AMINO ACIDS MARKET 185

TABLE 228 ACQUISITIONS 185

TABLE 229 EXPANSIONS 185

TABLE 230 AGREEMENTS 186

TABLE 231 MERCK KGAA: PRODUCTS/SERVICES OFFERED 188

TABLE 232 AJINOMOTO CO., INC.: PRODUCTS/SERVICES OFFERED 192

TABLE 233 AJINOMOTO CO., INC.: KEY DEVELOPMENTS 192

TABLE 234 BASF SE: PRODUCTS/SERVICES OFFERED 195

TABLE 235 BASF SE: KEY DEVELOPMENTS 195

TABLE 236 ENZO LIFE SCIENCES, INC.: PRODUCTS/SERVICES OFFERED 198

TABLE 237 ENZO LIFE SCIENCES, INC: KEY DEVELOPMENTS 198

TABLE 238 AMINOLOGICS CO., LTD: PRODUCTS/SERVICES OFFERED 200

TABLE 239 ANASPEC, INC.: PRODUCTS/SERVICES OFFERED 203

TABLE 240 HANHONG SCIENTIFIC: PRODUCTS/SERVICES OFFERED 205

TABLE 241 BIO-TECHNE CORPORATION: PRODUCTS/SERVICES OFFERED 209

TABLE 242 TOKYO CHEMICAL INDUSTRY CO., LTD: PRODUCTS/SERVICES OFFERED 211

TABLE 243 YONEYAMA YAKUHIN KOGYO CO., LTD: PRODUCTS/SERVICES OFFERED 214

14 LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 17

FIGURE 2 GLOBAL UNNATURAL AMINO ACIDS MARKET STRUCTURE 18

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 25

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL UNNATURAL AMINO ACIDS MARKET 28

FIGURE 5 DRIVERS IMPACT ANALYSIS 30

FIGURE 6 RESTRAINTS IMPACT ANALYSIS 31

FIGURE 7 PORTERโ€™S FIVE FORCES ANALYSIS: GLOBAL UNNATURAL AMINO ACIDS MARKET 32

FIGURE 8 VALUE CHAIN ANALYSIS OF THE GLOBAL UNNATURAL AMINO ACIDS MARKET 34

FIGURE 9 GLOBAL UNNATURAL AMINO ACIDS MARKET SHARE, BY TYPE, 2023 (%) 36

FIGURE 10 GLOBAL UNNATURAL AMINO ACIDS MARKET, BY TYPE, 2023 AND 2030 (USD MILLION) 37

FIGURE 11 GLOBAL UNNATURAL AMINO ACIDS MARKET SHARE, BY APPLICATION, 2023 (%) 46

FIGURE 12 GLOBAL UNNATURAL AMINO ACIDS MARKET, BY APPLICATION, 2023 AND 2030 (USD MILLION) 47

FIGURE 13 GLOBAL UNNATURAL AMINO ACIDS MARKET SHARE, BY END USER, 2023 (%) 50

FIGURE 14 GLOBAL UNNATURAL AMINO ACIDS MARKET, BY END USER, 2023 AND 2030 (USD MILLION) 51

FIGURE 15 GLOBAL UNNATURAL AMINO ACIDS MARKET SHARE, BY REGION, 2023 (%) 54

FIGURE 16 GLOBAL UNNATURAL AMINO ACIDS MARKET, BY REGION, 2023 AND 2030 (USD MILLION) 55

FIGURE 17 AMERICAS: UNNATURAL AMINO ACIDS MARKET, BY REGION, 2023 AND 2030 (USD MILLION) 56

FIGURE 18 NORTH AMERICA: UNNATURAL AMINO ACIDS MARKET, BY COUNTRY, 2023 AND 2030 (USD MILLION) 62

FIGURE 19 EUROPE: UNNATURAL AMINO ACIDS MARKET, BY REGION, 2023 AND 2030 (USD MILLION) 83

FIGURE 20 WESTERN EUROPE: UNNATURAL AMINO ACIDS MARKET, BY COUNTRY, 2023 AND 2030 (USD MILLION) 89

FIGURE 21 ASIA-PACIFIC: UNNATURAL AMINO ACIDS MARKET, BY COUNTRY, 2023 AND 2030 (USD MILLION) 130

FIGURE 22 MIDDLE EAST & AFRICA: UNNATURAL AMINO ACIDS MARKET, BY REGION, 2023 AND 2030 (USD MILLION) 166

FIGURE 23 BENCHMARKING OF MAJOR COMPETITORS 183

FIGURE 24 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN THE GLOBAL UNNATURAL AMINO ACIDS MARKET 184

FIGURE 25 GLOBAL UNNATURAL AMINO ACIDS MARKET, KEY DEVELOPMENTS & GROWTH STRATEGIES (%) 185

FIGURE 26 MERCK KGAA: FINANCIAL OVERVIEW 188

FIGURE 27 MERCK KGAA: SWOT ANALYSIS 190

FIGURE 28 AJINOMOTO CO., INC.: FINANCIAL OVERVIEW SNAPSHOT 191

FIGURE 29 AJINOMOTO CO., INC.: SWOT ANALYSIS 193

FIGURE 30 BASF SE: FINANCIAL OVERVIEW SNAPSHOT 194

FIGURE 31 BASF SE: SWOT ANALYSIS 195

FIGURE 32 ENZO LIFE SCIENCES, INC.: FINANCIAL OVERVIEW SNAPSHOT 197

FIGURE 33 ENZO LIFE SCIENCES, INC.: SWOT ANALYSIS 198

FIGURE 34 AMINOLOGICS CO., LTD: SWOT ANALYSIS 201

FIGURE 35 KANEKA CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 202

FIGURE 36 ANASPEC, INC.: SWOT ANALYSIS 204

FIGURE 37 HANHONG SCIENTIFIC: SWOT ANALYSIS 206

FIGURE 38 BIO-TECHNE CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 208

FIGURE 39 BIO-TECHNE CORPORATION: SWOT ANALYSIS 209

FIGURE 40 TOKYO CHEMICAL INDUSTRY CO., LTD: SWOT ANALYSIS 212

FIGURE 41 YONEYAMA YAKUHIN KOGYO CO., LTD: SWOT ANALYSIS 215

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.